ARCHIVES

PDQ Used Mainly For Information To Public, Not Much By Non-Oncologists, Evaluation Finds

This article is from The Cancer Letter archive.

Vol. 15 No. 33 | August 18, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: George Vande Woude To Wistar institute Board; Donald Pinkel To Head Pediatric Leukemia Program

October 18, 1985

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

8 Pittsburg Employees Started Coalition That Lasted 8 Days

June 10, 1994

Elderly Patients Fail To Receive New Cancer Therapy For CML

August 27, 2010

DCPC Developing Hispanic Cancer Control Intervention Program Concept

August 12, 1988

DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year

February 27, 1987